This week: Te Pūnaha Matatini principal investigators, an Auckland appointment and a Scott Base date
In depth: A Covid-19 vaccine developed in New Zealand has 100 per cent effectiveness in mice and the potential to cause fewer side effects and prevent the virus from replicating, a paper has said.
Full story: New Zealand Covid-19 vaccine works, alliance says
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.